| Size | Price | Stock |
|---|---|---|
| 25mg | $66 | In-stock |
| 50mg | $106 | In-stock |
| 100mg | $145 | In-stock |
| 200mg | $238 | In-stock |
| 500 mg | Get quote | |
| 1 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-15067 |
| M.Wt: | 252.14 |
| Formula: | C8H4N4O6 |
| Purity: | >98 % |
| Solubility: | DMSO : ≥ 35 mg/mL;H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) |
DNQX (FG 9041), a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively)[1]. IC50 & Target:Non-NMDA Glutamate Receptor[1] In Vitro:DNQX selectively depolarizes thalamic reticular nucleus (TRN) neurons[2]. In Vivo:DNQX, a specific AMPA receptor antagonist, given as either a 5 mg/kg or 10 mg/kg intraperitoneal dose or into the lateral cerebral ventricle (5 μL of 0.5 mg/mL) significantly diminishes phencyclidine (PCP) (40 mg/kg) hsp70 induction in the posterior cingulate and retrosplenial cortex[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.